Revvity Inc

RVTY: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$355.00TgqhxmzGdmrhrvf

Raising Fair Value Estimate on Narrow-Moat PerkinElmer on Strong Prospects

Business Strategy and Outlook

With myriad acquisitions in the past few years, PerkinElmer has been in a constant state of evolution since 2016 when the company transitioned into two new business segments, Diagnostics and Discovery and Analytical Solutions (DAS), with life sciences being the most attractive segment of the DAS business. We are confident that the firm’s renewed strategic focus on improving its diagnostic product mix and life sciences business will sustain returns over cost of capital and produce tangible benefits for shareholders in the long run.

Sponsor Center